BIIB•benzinga•
Leqembi And Skyclarys Expected To Drive Biogen's Future Growth: Analysts
Summary
Biogen's Q4 EPS and revenue topped estimates, but analysts cite Medicare changes and MS declines as headwinds. Leqembi and Skyclarys remain key growth drivers.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on February 13, 2025 by benzinga